0001140361-21-017512.txt : 20210514 0001140361-21-017512.hdr.sgml : 20210514 20210514202643 ACCESSION NUMBER: 0001140361-21-017512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210512 FILED AS OF DATE: 20210514 DATE AS OF CHANGE: 20210514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Merton Carl A CENTRAL INDEX KEY: 0001860546 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 21927030 MAIL ADDRESS: STREET 1: C/O TILRAY, INC. STREET 2: 745 FIFTH AVENUE, SUITE 1602 CITY: NEW YORK STATE: NY ZIP: 10151 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 824310622 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 745 FIFTH AVENUE STREET 2: SUITE 1602 CITY: NEW YORK STATE: NY ZIP: 10151 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 745 FIFTH AVENUE STREET 2: SUITE 1602 CITY: NEW YORK STATE: NY ZIP: 10151 4 1 form4.xml FORM 4 X0306 4 2021-05-12 0001731348 Tilray, Inc. TLRY 0001860546 Merton Carl A C/O TILRAY, INC. 745 FIFTH AVENUE, SUITE 1602 NEW YORK NY 10151 true Chief Financial Officer Class 2 Common Stock 2021-05-12 4 S 0 89000 14.82 D 169105 D The shares were sold to satisfy tax obligations of the reporting person incurred in connection with the closing of the plan of arrangement (the "Arrangement") between Tilray, Inc. and Aphria Inc. on April 30, 2021, pursuant to which each common share of Aphria Inc. was exchanged for 0.8381 of a share of Class 2 common stock of Tilray, Inc.. The Arrangement was considered a taxable event for Canadian shareholders of Aphria Inc. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from CAD $17.80 to CAD $18.10, inclusive. The reporting person undertakes to provide to Tilray, Inc. any security holder of Tilray, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). The weighted average price reported above was converted from the Canadian weighted average price of CAD $17.9857 to USD using an exchange rate of CAD $1.2133=USD $1.00. /s/ Carl A. Merton 2021-05-14